Skip to main content
Livermore
Livermore
ZHEN

EDBI Pte Ltd

SEC CIK
0001913506
Latest filing
Feb 4, 2025

KROS holding history

Keros Therapeutics, Inc. in every 13F filed by EDBI Pte Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KROS overviewAll 13F holders of KROSFull Q4 2024 holdings

Shares (Q4 2024)
10,105
Value
$160.0K
% of portfolio
0.2%
Quarters held
13
Since Q4 2021
Holdings of KROS by EDBI Pte Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 202410,105$160.0K0.2%00.0%UnchangedHolders
Q3 202410,105$586.8K0.8%00.0%UnchangedHolders
Q2 202410,105$461.8K0.5%00.0%UnchangedHolders
Q1 202410,105$669.0K0.8%00.0%UnchangedHolders
Q4 202310,105$401.8K0.4%00.0%UnchangedHolders
Q3 202310,105$322.1K0.3%00.0%UnchangedHolders
Q2 202310,105$406.0K0.3%00.0%UnchangedHolders
Q1 202310,105$431.5K0.5%00.0%UnchangedHolders
Q4 202210,105$485.2K0.6%00.0%UnchangedHolders
Q3 202210,105$380.0K0.4%00.0%UnchangedHolders
Q2 202210,105$279.0K0.3%00.0%UnchangedHolders
Q1 202210,105$550.0K0.4%00.0%UnchangedHolders
Q4 202110,105$591.0K0.3%–No prior filingHolders